Jon Edelson is the founder of Eirion Therapeutics. Eirion Therapeutics has raised $40M in total funding. Latest round: Series A.
Jon Edelson, MD, is the Chairman, CEO, and President of Eirion Therapeutics, a biopharmaceutical company focused on developing prescription products for aesthetic medicine, including treatments for hair loss, wrinkles, and hair greying. He leads the company's clinical development of ET-02, a product that has shown a significant increase in non-vellus hair count by reactivating hair follicle stem cells. Edelson previously held a role as a Venture Partner while serving in his executive capacity at Eirion.
Full founder directory · Investor directory · Company funding database · Fundraising library